135 related articles for article (PubMed ID: 12712872)
1. [Interaction of donepezil and muscular blockers in Alzheimer's disease].
Sánchez Morillo J; Demartini Ferrari A; Roca de Togores López A
Rev Esp Anestesiol Reanim; 2003 Feb; 50(2):97-100. PubMed ID: 12712872
[TBL] [Abstract][Full Text] [Related]
2. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
3. The pharmacology of donepezil: a new treatment of Alzheimer's disease.
Wilkinson DG
Expert Opin Pharmacother; 1999 Nov; 1(1):121-35. PubMed ID: 11249555
[TBL] [Abstract][Full Text] [Related]
4. Donepezil: an update.
Seltzer B
Expert Opin Pharmacother; 2007 May; 8(7):1011-23. PubMed ID: 17472546
[TBL] [Abstract][Full Text] [Related]
5. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
Sugimoto H
Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
[TBL] [Abstract][Full Text] [Related]
6. The effect of donepezil treatment on cardiovascular mortality.
Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
[TBL] [Abstract][Full Text] [Related]
7. Donepezil, Alzheimer's disease and suxamethonium.
Heath ML
Anaesthesia; 1997 Oct; 52(10):1018. PubMed ID: 9370854
[No Abstract] [Full Text] [Related]
8. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
Adunsky A; Chesnin V; Ravona R; Harats D; Davidson M
Arch Gerontol Geriatr; 2004; 38(1):61-8. PubMed ID: 14599705
[TBL] [Abstract][Full Text] [Related]
9. Beyond symptomatic effects: potential of donepezil as a neuroprotective agent and disease modifier in Alzheimer's disease.
Kim SH; Kandiah N; Hsu JL; Suthisisang C; Udommongkol C; Dash A
Br J Pharmacol; 2017 Dec; 174(23):4224-4232. PubMed ID: 28901528
[TBL] [Abstract][Full Text] [Related]
10. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
[TBL] [Abstract][Full Text] [Related]
11. A 10-year perspective on donepezil.
Cheewakriengkrai L; Gauthier S
Expert Opin Pharmacother; 2013 Feb; 14(3):331-8. PubMed ID: 23316713
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
13. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
Azanza JR; Sádaba B; Quetglas EG; Escolar M
Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
[No Abstract] [Full Text] [Related]
14. Donepezil improved memory in multiple sclerosis in a randomized clinical trial.
Tsao JW; Heilman KM
Neurology; 2005 May; 64(10):1823; author reply 1823. PubMed ID: 15911833
[No Abstract] [Full Text] [Related]
15. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report.
Zaidel L; Allen G; Cullum CM; Briggs RW; Hynan LS; Weiner MF; McColl R; Gopinath KS; McDonald E; Rubin CD
J Alzheimers Dis; 2012; 31 Suppl 3(0 3):S221-6. PubMed ID: 22886013
[TBL] [Abstract][Full Text] [Related]
16. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E
Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138
[TBL] [Abstract][Full Text] [Related]
17. Response to letter from Garcia and colleagues on cholinesterase inhibitors and Alzheimer's disease outcomes.
Gillette-Guyonnet S; Andrieu S; Nourhashemi F; Reynish E; Vellas B
J Gerontol A Biol Sci Med Sci; 2007 Jun; 62(6):679-80. PubMed ID: 17595427
[No Abstract] [Full Text] [Related]
18. [Donepezil-induced neuroprotection of acetylcholinergic neurons in olfactory bulbectomized mice].
Yamamoto Y; Shioda N; Han F; Moriguchi S; Fukunaga K
Yakugaku Zasshi; 2010 May; 130(5):717-21. PubMed ID: 20460870
[TBL] [Abstract][Full Text] [Related]
19. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
Vollmar HC; Butzlaff M
Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
[No Abstract] [Full Text] [Related]
20. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
